Free Trial
OTCMKTS:GLUC

Glucose Health 11/8/2024 Earnings Results & Report

Glucose Health logo
$0.34 -0.02 (-5.11%)
As of 01:24 PM Eastern

Glucose Health reported earnings on November 8, 2024. The company reported EPS of -$0.01, while revenue was $0.07 million.

Earnings Announcement Details

Report Date
Time
Before Market Opens

Glucose Health EPS Results

Actual EPS
-$0.01
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Glucose Health Revenue Results

Actual Revenue
$0.07 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Conference Call Resources

Glucose Health Earnings FAQ

Glucose Health (OTCMKTS:GLUC) reported earnings of -$0.01 per share for the quarter. The report was announced on Friday, November 8, 2024.

Glucose Health reported revenue of $0.07 million for the quarter.

Glucose Health Earnings Headlines

8 teas that can help lower blood sugar
“The crisis that’s emerging now is just the tip of the iceberg,” says Dr. Martin D. Weiss, who has made shocking and accurate predictions for 55 years
Dr. Martin D. Weiss, who predicted the Dot-Com collapse and the failures of Fannie Mae, Bear Stearns, and Lehman Brothers, is warning of a developing financial crisis. The New York Times has credited him as among the first to see the dangers ahead, and Forbes dubbed him Mr. Independence. He says this emerging situation could trigger a chain reaction across banks and markets. Watch his free video breakdown and see the five steps he outlines for investors.tc pixel
See More Glucose Health Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Glucose Health? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Glucose Health and other key companies, straight to your email.

About Glucose Health

Glucose Health (OTCMKTS:GLUC) is a consumer health company focused on developing and marketing nutritional products intended to support healthy blood glucose levels and metabolic wellness. The company’s offerings are positioned as dietary supplements and functional nutrition products rather than prescription medicines.

Its principal product has been GlucoDown, a powdered drink mix marketed for use as part of a daily wellness routine. The product is formulated with nutritional ingredients intended to support blood sugar management, and is sold directly to consumers through online channels.

Publicly available information about Glucose Health’s operating history, geographic reach, and current leadership is limited. The company’s business has primarily been associated with the development, promotion, and sale of its branded glucose-support products.

View Glucose Health Profile